Dr. Kocour and Dr. Murray on embolization of the prostate
“A majority of the patients who were referred who had a catheter pre embolization are now catheter free,” says Kimberly Kocour, MD.
In this video, Kimberly Kocour, MD, and Katie Murray, DO, MS, discuss the rationale and notable findings from the South Central Section of the AUA Annual Meeting abstract, "Prostatic artery embolization: an option for select male patients with necessary collaboration between urology and interventional radiology." Murray is an assistant professor at the University of Missouri Division of Urology in Columbia. Kocour is a urology resident at the University of Missouri.
Lenvatinib/pembrolizumab compares favorably with frontline standards in renal cell carcinoma
February 2nd 2024“Combination therapy with lenvatinib plus pembrolizumab provides a comparable OS, and a trend of improvement in PFS and response outcomes, compared with most current global SOC therapies for treatment-naïve patients with advanced renal cell carcinoma,” the study authors wrote.
First-line pembrolizumab/lenvatinib shows efficacy for advanced non–clear cell RCC
January 29th 2024“Updated efficacy and safety results continue to support pembrolizumab plus lenvatinib as a first-line treatment option for patients with advanced non–clear cell RCC,” lead study author Martin H. Voss, MD.
